PETS
Petmed Express Inc
$1.91
-0.05 (-2.55%)
At close · Jul 13
Going-concern doubt
— cleared Jun 2, 2026
The latest filing states the doubt was alleviated.
“The Company’s liquidity position at March 31, 2026 has been impacted by declining cash balances, declining net sales, recurring operating losses and for fiscal 2026, negative operating cash flows. When considered in the aggregate, these conditions raised substantial doubt about the Company's ability to continue as a going concern within the assessment period, defined as twelve months after the date that our consolidated financial statements are issued. Management evaluated the significance of these conditions in relation to the Company’s ability to meet its obligations within the assessment period and has developed a plan intended to alleviate substantial doubt. The primary elements of the plan include, among other things, advertising and media spend optimization, strategic reductions in operating expenses, including decreases in professional fees following the resolution of non-recurring matters, and reductions in capital expenditures. Management determined that these plans are probable of being effectively implemented and are probable of mitigating the conditions that raised substantial doubt and has concluded that substantial doubt about the Company’s ability to continue as a going concern for the twelve-month period following issuance of these consolidated financial statements has been alleviated.”View the 10-K filed Jun 2, 2026
Market Cap
$40.81M
Shares
21,365,782
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$179.02M
-21.1%
FY2026
Net Income
-$57.29M
-813.7%
FY2026
Gross Margin
28.05%
-2.4pp
FY2026
Operating Margin
-32.77%
-32.1pp
FY2026
Diluted EPS
-$2.74
-813.3%
FY2026
Operating Cash Flow
-$28.39M
-701.8%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $179.02M | $226.97M | $274.1M | $256.58M | $273.42M | $309.22M | $284.13M | $283.42M | $273.8M | — | — | — | — | — | — | |
| $142.37M | — | $157.84M | $202.42M | $185.84M | $195.34M | $219.27M | $202.88M | $188.11M | $175.99M | $169.86M | $158.39M | $153.13M | $155.77M | $150.71M | $158.09M | |
| — | $50.22M | $69.14M | $84.77M | $70.74M | $78.08M | $89.95M | $81.25M | $95.31M | $97.81M | $79.31M | $76.3M | $76.27M | $77.62M | $77.12M | $80.17M | |
| — | 28.05% | 30.46% | 30.93% | 27.57% | 28.56% | 29.09% | 28.6% | 33.63% | 35.72% | — | — | — | — | — | — | |
| — | $50.73M | $38.65M | $55.25M | $41.71M | $30.83M | $28.29M | $25.26M | $24.77M | $24.29M | $22.8M | $21.3M | $21.1M | $21.35M | $21.59M | $22.36M | |
| — | $2M | $2M | $2M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $9.39M | $7.04M | $7.06M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $108.89M | $70.67M | $92.93M | $64.68M | $52.37M | $52.36M | $50.27M | $49.14M | $45.67M | $41.83M | $43.91M | $48.66M | $49.4M | $50.12M | $54.14M | |
| — | -$58.67M | -$1.53M | -$8.16M | $6.05M | $25.71M | $37.59M | $30.98M | $46.17M | $52.14M | $37.48M | $32.39M | $27.61M | $28.22M | $27.01M | $26.02M | |
| — | -32.77% | -0.67% | -2.98% | 2.36% | 9.4% | 12.16% | 10.9% | 16.29% | 19.04% | — | — | — | — | — | — | |
| — | -$49.29M | $5.51M | -$1.11M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | $2.07M | $335K | $314K | $1.75M | $1.86M | $658K | $141K | $190K | $184K | $185K | $306K | $288K | |
| — | $1.31M | $943K | $1.89M | $1.39M | $1.36M | $1.63M | $2.92M | $2.95M | $1.65M | $441K | $179K | $185K | $181K | $301K | $349K | |
| — | -$57.36M | -$587K | -$6.27M | $7.45M | $27.07M | $39.22M | $33.89M | $49.12M | $53.79M | $37.92M | $32.57M | $27.8M | $28.4M | $27.31M | $26.37M | |
| — | -$73K | $5.68M | $1.19M | $2.31M | $5.97M | $8.61M | $8.04M | $11.38M | $16.51M | $14.11M | $12M | $10.35M | $10.43M | $10.14M | $9.71M | |
| — | -$57.29M | -$6.27M | -$7.46M | $5.14M | $21.1M | $30.6M | $25.85M | $37.74M | $37.28M | $23.82M | $20.57M | $17.45M | $17.97M | $17.17M | $16.66M | |
| — | -32% | -2.76% | -2.72% | 2% | 7.72% | 9.9% | 9.1% | 13.32% | 13.62% | — | — | — | — | — | — | |
| $25.47M | — | — | — | — | — | — | — | $37.74M | $37.28M | $23.82M | $20.62M | $17.44M | $17.94M | $17.12M | — | |
| USD/shares | — | -$2.74 | -$0.30 | -$0.37 | $0.25 | $1.05 | $1.53 | $1.29 | $1.84 | $1.83 | $1.18 | $1.02 | $0.87 | $0.90 | $0.86 | $0.81 |
| USD/shares | — | -$2.74 | -$0.30 | -$0.37 | $0.25 | $1.04 | $1.52 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | $0.87 | $0.90 | $0.86 | $0.80 |
| shares | — | 20.92M | 20.6M | 20.4M | 20.28M | 20.18M | 20.06M | 20.04M | 20.46M | 20.35M | 20.23M | 20.12K | 20.02M | 19.9M | 19.93M | 20.61M |
| shares | — | 20.92M | 20.6M | 20.4M | 20.34M | 20.36M | 20.12M | 20.06M | 20.49M | 20.43M | 20.38M | 20.25K | 20.14M | 20.04M | 20.05M | 20.71M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2026: $46.78M in buybacks, $245.71M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Reportable Segment | $179,021,000 | $226,972,000 | $274,095,000 | $247,569,000 |